Maximus (NYSE:MMS) Updates FY 2026 Earnings Guidance

Maximus (NYSE:MMS) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 8.250-8.550 for the period, compared to the consensus earnings per share estimate of 8.360. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on MMS. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings cut shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. Finally, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Maximus Trading Down 3.6%

Shares of NYSE MMS traded down $2.38 during trading on Friday, hitting $64.28. 886,929 shares of the company traded hands, compared to its average volume of 720,506. Maximus has a 1 year low of $60.75 and a 1 year high of $100.00. The company has a 50-day moving average price of $68.82 and a 200-day moving average price of $80.01. The firm has a market capitalization of $3.51 billion, a P/E ratio of 9.78 and a beta of 0.60. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.98 by $0.09. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same period in the previous year, the company earned $2.01 EPS. The business’s quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, equities analysts predict that Maximus will post 8.33 EPS for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 annualized dividend and a dividend yield of 2.1%. Maximus’s payout ratio is currently 20.09%.

Insider Activity

In other news, Director Jan Madsen sold 742 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares of the company’s stock, valued at $1,502,438.75. The trade was a 3.45% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO David Mutryn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Monday, February 9th. The shares were acquired at an average cost of $75.62 per share, with a total value of $75,620.00. Following the completion of the transaction, the chief financial officer owned 40,037 shares in the company, valued at $3,027,597.94. This trade represents a 2.56% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 1.80% of the company’s stock.

Maximus News Roundup

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Q2 EPS beat consensus ($2.07 vs. $1.98), demonstrating operating profitability despite top?line pressure; profitability metrics (ROE, net margin) remain strong. Maximus (MMS) Q2 Earnings Beat Estimates
• Positive Sentiment: Management raised its near?term adjusted EBITDA margin target to 12%–15% and issued FY?2026 adjusted EPS guidance of $8.25–$8.55, signaling confidence in margin expansion and cost discipline. Maximus forecasts $8.25-$8.55 FY 2026 adjusted EPS while raising near-term adjusted EBITDA margin target to 12%-15%
• Neutral Sentiment: FY?2026 guidance (EPS and revenue $5.2B–$5.4B) sits around Street expectations rather than meaningfully exceeding them, so the update is more status?quo than bullish. Maximus Reports Fiscal Year 2026 Second Quarter Results
• Neutral Sentiment: Company commentary emphasized technology?driven efficiency offsetting revenue headwinds — positive for margin trajectory but not an immediate revenue fix. MMS Q1 deep dive: Technology-driven efficiency offsets revenue headwinds, margin outlook raised
• Negative Sentiment: Revenue missed estimates ($1.31B reported vs. ~$1.32B expected) and was down ~4.1% year?over?year — the top?line weakness likely drove investor concern despite the EPS beat. Maximus (NYSE:MMS) Misses Q1 CY2026 Revenue Estimates

Institutional Trading of Maximus

Institutional investors have recently added to or reduced their stakes in the business. Advisory Services Network LLC acquired a new position in Maximus in the 3rd quarter worth $32,000. Canada Pension Plan Investment Board acquired a new position in Maximus in the 2nd quarter worth $35,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Maximus by 225.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after buying an additional 304 shares in the last quarter. Danske Bank A S acquired a new position in Maximus in the 3rd quarter worth $55,000. Finally, Kestra Advisory Services LLC acquired a new position in Maximus in the 4th quarter worth $89,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.